Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Radiother. 2004 Nov;8 Suppl 1:S73-9.

[Surgical resection of pancreatic adenocarcinoma: indications and contraindications, pronostic factors and survival, recent advances].

[Article in French]

Author information

1
D├ępartement de chirurgie, institut Paoli-Calmettes, 232, boulevard de Sainte-Marguerite, 13009, Marseille, France. jrdelpero@wanadoo.fr

Abstract

The resection rate for pancreatic adenocarcinoma is only 10%. Curative resection remains the most important factor determining outcome for resectable pancreatic adenocarcinoma. Since 1990, an improvement on survival rate was observed, but the reasons are unclear: this improvement may be related to a more effective patient selection, more radical resection or adjuvant treatment strategies. The value of more radical resection remains open to debate, despite the negative results of two recent randomized trials with standard versus extended lymphadenectomy. The overall five-year survival rate after resection is still about 10% to 20%; these poor results emphasized the need for a best patient selection, the research of new preoperative prognostic factors, and randomized trials of neoadjuvant or adjuvant treatments.

PMID:
15679251
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center